Early access: 15,549 bills from the current Congress so far, more added daily. Data from Congress.gov, GovInfo and the House and Senate vote records, updated Oct 13, 2026.
Public Law TrackerPLTPublic Law Tracker

H.R. 9682 · Where this bill is now

In committee

Introduced in the House, sent to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Natural Resources, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned, Jul 14, 2026

What this bill does

In plain words · AI-written from the official summary

Free hepatitis C treatment for vulnerable groups

This bill sets up free hepatitis C medications and testing programs for people who can't easily afford treatment. The government would negotiate contracts with drug makers to provide treatments at no cost to eligible patients, and would fund grants to help states, health organizations, and correctional facilities coordinate screening and care.

How it affects you

If you have hepatitis C and are uninsured, enrolled in Medicaid or CHIP, in a correctional facility, or receive care through the Indian Health Service, you'd be able to get hepatitis C drugs without paying anything. Medicare beneficiaries would also get free hepatitis C medications starting in 2028. For most other people, this mainly affects how public health and correctional systems operate in your state.

Read the official summary (Introduced in House, Jul 14, 2026)

Cure Hepatitis C Act of 2026

This bill establishes programs and requirements to provide free medications to treat hepatitis C in certain high-risk or vulnerable populations. It also establishes grants and other resources to support testing and treatment for hepatitis C. The bill provides funding for FY2027 to implement these provisions.

The Department of Health and Human Services (HHS) must enter into a five-year purchasing contract with manufacturers of drugs that treat hepatitis C so that eligible individuals may receive the drugs without cost-sharing. Eligible individuals are those diagnosed with hepatitis C who are (1) enrolled in Medicaid or the Children’s Health Insurance Program (CHIP), (2) confined to federal, state, or local correctional facilities (or were released and began treatment there), (3) uninsured, or (4) receiving health care through the Indian Health Service.

State Medicaid and CHIP programs and state and local correctional facilities may opt into the program; participation is mandatory for federal correctional facilities and the Indian Health Service.

HHS must award grants to certain entities, including states, public health organizations, and correctional facilities, to support the coordination and provision of screening, treatment, and supportive services for the affected populations.

The bill also allows Medicare beneficiaries to receive hepatitis C drugs without cost-sharing from 2028-2032.

Written by AI (Claude) using only the official summary by the Congressional Research Service, the Library of Congress’s nonpartisan research staff. It can miss nuance, so check the official summary and the bill text for details.

119th Congress
2nd SessionH. R. 9682

A BILL

Cure Hepatitis C Act of 2026

In the HouseNo vote yet

Sponsor: Rep. Mariannette Miller-Meeks (R-IA-1) · Introduced Jul 14, 2026 · Health · 1 version of the text

Read the full billOfficial record on Congress.gov ↗

Sources: Congress.gov actions and votes · bill text from GovInfo · latest official action Jul 14, 2026: “Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Natural Resources, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.”

Sections

Sections · 9